Protein profiling of bladder cancer using the 2D-PAGE and SELDI-TOF-MS technique

被引:39
作者
Langbein, S [1 ]
Lehmann, J
Harder, A
Steidler, A
Michel, MS
Alken, P
Badawi, JK
机构
[1] Univ Hosp, Dept Urol, D-68167 Mannheim, Germany
[2] Univ Amsterdam, Acad Med Ctr, Dept Urol, NL-1100 DD Amsterdam, Netherlands
[3] Univ Saarland, Dept Urol & Pediat Urol, D-66421 Homburg, Germany
[4] Toplab GmbH, D-82152 Martinsried, Germany
关键词
actin-related proteins; bladder cancer; cytoskeletal proteins; 2D-PAGE; ProteinChip (R); SELDI-TOF-MS; urothelial carcinoma;
D O I
10.1177/153303460600500109
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Protein profiling is a promising tool for tumor characterization and the detection of tumor markers in bladder cancer. Techniques for 2-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and surface-enhanced laser desorption/ionization with time-of-flight mass spectrometry (SELDI-TOF-MS) have improved; both were evaluated using bladder tumor tissue. Normal urothelium and pTa G2, pT1 G3, and >= pT3 G3 tissues were obtained from the operating room and, after macrodissection, subjected to 2D-PAGE and to SELDI-TOF-MS ProteinChip(R). 2D-PAGE gels expressed significantly different protein patterns for pTa G2 and pT3 G3 tumors. pT1 G3 tumors showed expression profiles similar to those of the invasive tumors, with upregulation of galectin 3, gelsolin, villin 2, moesin, and annexin 6. Similarly, distinct protein peaks were detected for superficial and muscle-invasive urothelial cancers by SELDI-TOF-MS. Six of seven superficial pTa G2 tumors showed an intense peak at 6.7 and 10.1 kD, while invasive carcinomas showed an intense peak near 9.5 kD. No disturbing influence of surrounding tissue on the results was detected. It was shown that both techniques (2D-PAGE and ProteinChip) work well, and especially ProteinChip analysis seems promising for clinical application.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 21 条
[1]
The health economics of bladder cancer - A comprehensive review of the published literature [J].
Botteman, MF ;
Pashos, CL ;
Redaelli, A ;
Laskin, B ;
Hauser, R .
PHARMACOECONOMICS, 2003, 21 (18) :1315-1330
[2]
Proteomics in translational cancer research: Toward an integrated approach [J].
Celis, JE ;
Gromov, P .
CANCER CELL, 2003, 3 (01) :9-15
[3]
Impact of proteomics on bladder cancer research [J].
Celis, JE ;
Gromova, I ;
Moreira, JMA ;
Cabezón, T ;
Gromov, P .
PHARMACOGENOMICS, 2004, 5 (04) :381-394
[4]
ESRIG D, 1994, NEW ENGL J MED, V331
[5]
Detection of bladder cancer using a point-of-care proteomic assay [J].
Grossman, HB ;
Messing, E ;
Soloway, M ;
Tomera, K ;
Katz, G ;
Berger, Y ;
Shen, Y .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (07) :810-816
[6]
Ezrin/radixin/moesin proteins and Rho GTPase signalling in leucocytes [J].
Ivetic, A ;
Ridley, AJ .
IMMUNOLOGY, 2004, 112 (02) :165-176
[7]
What we could do now: molecular pathology of bladder cancer [J].
Knowles, MA .
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2001, 54 (04) :215-221
[8]
Koed K, 2005, CANCER RES, V65, P34
[9]
Functions of gelsolin: motility, signaling, apoptosis, cancer [J].
Kwiatkowski, DJ .
CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (01) :103-108
[10]
Alteration of the LRP1B gene region is associated with high grade of urothelial cancer [J].
Langbein, S ;
Szakacs, O ;
Wilhelm, M ;
Sukosd, F ;
Weber, S ;
Jauch, A ;
Beltran, AL ;
Alken, P ;
Kälble, T ;
Kovacs, G .
LABORATORY INVESTIGATION, 2002, 82 (05) :639-643